Literature DB >> 18664054

Vulvodynia as a somatoform disorder.

Peter J Lynch1.   

Abstract

Chronic vulvar pain can occur either as a result of a recognizable, underlying vulvar disorder or as an idiopathic process known as vulvodynia. It is widely recognized that most patients with vulvodynia have some degree of associated psychosexual distress. Most clinicians currently believe that the long-term presence of pain, arising as a local process involving either the innervation of the vulva or a low-grade inflammatory process of vulvar tissue, is sufficient to explain the development of secondary psychosexual problems. This explanation may be termed the neuropathic hypothesis. Alternatively, a minority of clinicians believes that the reverse is true and that vulvodynia develops as a result of pre-existing psychosexual dysfunction which, due to various precipitating factors, is subsequently expressed as chronic vulvar pain. This explanation may be termed the somatoform hypothesis. This review summarizes the evidence supporting the somatoform hypothesis and concludes that psychosocial factors may be the primary factor responsible for chronic "idiopathic" anogenital pain in both men and women. Moreover, since current treatment for vulvodynia is controversial and only partially effective, the therapeutic implications of a somatoform etiology are of considerable importance.

Entities:  

Mesh:

Year:  2008        PMID: 18664054

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

1.  Chemotherapeutic Agent-Induced Vulvodynia, an Experimental Model.

Authors:  Srinath Rangappa; Vijay Kumar Shankar; Seongbong Jo; Michael A Repka; S Narasimha Murthy
Journal:  AAPS PharmSciTech       Date:  2021-03-08       Impact factor: 3.246

2.  A Role for Bradykinin Signaling in Chronic Vulvar Pain.

Authors:  Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Constantine G Haidaris; Richard P Phipps
Journal:  J Pain       Date:  2016-08-18       Impact factor: 5.820

Review 3.  A review of the available clinical therapies for vulvodynia management and new data implicating proinflammatory mediators in pain elicitation.

Authors:  M L Falsetta; D C Foster; A D Bonham; R P Phipps
Journal:  BJOG       Date:  2016-06-17       Impact factor: 6.531

4.  A Pilot Proteomic Study of Vestibular Fluid From Patients With Vulvodynia.

Authors:  Colin MacNeill; Todd Umstead; Debra Shearer; Judith Weisz; David S Phelps; Joanna Floros
Journal:  J Low Genit Tract Dis       Date:  2022-04-01       Impact factor: 1.925

Review 5.  Etiology, diagnosis, and clinical management of vulvodynia.

Authors:  Leslie A Sadownik
Journal:  Int J Womens Health       Date:  2014-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.